PubMed

Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia.

Biarnés M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E.

Diabetes. 2002 Jan;51(1):66-72.PMID: 11756324 [PubMed - indexed for MEDLINE]Related articlesFree article

Normoglycemia restores beta-cell replicative response to glucose in transplanted islets exposed to chronic hyperglycemia.

Nacher V, Merino JF, Raurell M, Soler J, Montanya E.

Diabetes. 1998 Feb;47(2):192-6.PMID: 9519712 [PubMed - indexed for MEDLINE]Related articles

Optimal insulin treatment in syngeneic islet transplantation.

Merino JF, Nacher V, Raurell M, Biarnés M, Soler J, Montanya E.

Cell Transplant. 2000 Jan-Feb;9(1):11-8.PMID: 10784061 [PubMed - indexed for MEDLINE]Related articles

Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function.

Davalli AM, Scaglia L, Zangen DH, Hollister J, Bonner-Weir S, Weir GC.

Diabetes. 1996 Sep;45(9):1161-7.PMID: 8772716 [PubMed - indexed for MEDLINE]Related articles

Short-term culture with the caspase inhibitor z-VAD.fmk reduces beta cell apoptosis in transplanted islets and improves the metabolic outcome of the graft.

Montolio M, Téllez N, Biarnés M, Soler J, Montanya E.

Cell Transplant. 2005;14(1):59-65.PMID: 15789663 [PubMed - indexed for MEDLINE]Related articles

Improved outcome of islet transplantation in insulin-treated diabetic mice: effects on beta-cell mass and function.

Merino JF, Nacher V, Raurell M, Aranda O, Soler J, Montanya E.

Diabetologia. 1997 Sep;40(9):1004-10.PMID: 9300236 [PubMed - indexed for MEDLINE]Related articles

Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice.

Montaña E, Bonner-Weir S, Weir GC.

J Clin Invest. 1993 Mar;91(3):780-7.PMID: 8450059 [PubMed - indexed for MEDLINE]Related articlesFree article

Beta-cell growth and mass are preserved in long-term syngeneic islet transplantation in streptozocin-induced diabetic Lewis rats.

Nácher V, Raurell M, Merino JF, Aranda O, Soler J, Montana E.

Diabetes. 1996 Nov;45(11):1541-6.PMID: 8866559 [PubMed - indexed for MEDLINE]Related articles

Hyperglycemia-induced B cell toxicity. The fate of pancreatic islets transplanted into diabetic mice is dependent on their genetic background.

Korsgren O, Jansson L, Sandler S, Andersson A.

J Clin Invest. 1990 Dec;86(6):2161-8.PMID: 2254465 [PubMed - indexed for MEDLINE]Related articlesFree article

Adenoviral overproduction of interleukin-1 receptor antagonist increases beta cell replication and mass in syngeneically transplanted islets, and improves metabolic outcome.

Téllez N, Montolio M, Estil-les E, Escoriza J, Soler J, Montanya E.

Diabetologia. 2007 Mar;50(3):602-11. Epub 2007 Jan 13.PMID: 17221214 [PubMed - indexed for MEDLINE]Related articles

Hyperproliferative state of liver acini and pancreatic islets after intraportal transplantation of a small mass of islets of Langerhans in streptozotocininduced diabetic rats.

Dombrowski F, Pfeifer U.

Exp Clin Endocrinol Diabetes. 1995;103 Suppl 2:112-17.PMID: 8839266 [PubMed - indexed for MEDLINE]Related articles

Growth of intraportally transplanted islets under liver regeneration stimulus and restoration of normoglycemia in streptozocin-diabetic rats.

Morsiani E, Fogli L, Rozga J, Ricci D, Azzena G, Demetriou AA.

Surgery. 1998 Apr;123(4):398-406.PMID: 9551065 [PubMed - indexed for MEDLINE]Related articles

Exendin-4 treatment expands graft beta-cell mass in diabetic mice transplanted with a marginal number of fresh islets.

Juang JH, Kuo CH, Wu CH, Juang C.

Cell Transplant. 2008;17(6):641-7.PMID: 18819252 [PubMed - indexed for MEDLINE]Related articles

Recovery of pancreatic beta cells in response to long-term normoglycemia after pancreas or islet transplantation in severely streptozotocin diabetic adult rats.

Jörns A, Klempnauer J, Tiedge M, Lenzen S.

Pancreas. 2001 Aug;23(2):186-96.PMID: 11484921 [PubMed - indexed for MEDLINE]Related articles

Insulin-induced normoglycemia reduces islet number needed to achieve normoglycemia after allogeneic islet transplantation in diabetic mice.

Ferrer-Garcia JC, Merino-Torres JF, Pérez Bermejo G, Herrera-Vela C, Ponce-Marco JL, Piñon-Selles F.

Cell Transplant. 2003;12(8):849-57.PMID: 14763504 [PubMed - indexed for MEDLINE]Related articles

Prevention of hyperglycemia improves the long-term result of islet transplantation in streptozotocin-diabetic rats.

Ar'Rajab A, Ahrén B.

Pancreas. 1992;7(4):435-42.PMID: 1386465 [PubMed - indexed for MEDLINE]Related articles

Low-dose streptozocin-induced autoimmune diabetes in islet transplantation model.

Weide LG, Lacy PE.

Diabetes. 1991 Sep;40(9):1157-62.PMID: 1834505 [PubMed - indexed for MEDLINE]Related articles

Hepatocyte growth factor is essential for amelioration of hyperglycemia in streptozotocin-induced diabetic mice receiving a marginal mass of intrahepatic islet grafts.

Nakano M, Yasunami Y, Maki T, Kodama S, Ikehara Y, Nakamura T, Tanaka M, Ikeda S.

Transplantation. 2000 Jan 27;69(2):214-21.PMID: 10670629 [PubMed - indexed for MEDLINE]Related articles

Effect of 15-deoxyspergualin on immediate function and long-term survival of transplanted islets in murine recipients of a marginal islet mass.

Kaufman DB, Gores PF, Field MJ, Farney AC, Gruber SA, Stephanian E, Sutherland DE.

Diabetes. 1994 Jun;43(6):778-83.PMID: 8194663 [PubMed - indexed for MEDLINE]Related articles

The effect of preexisting long-term diabetes on the outcome after islet transplantation in rats.

Ar'Rajab A, Harris RB, Sentementes JT, Dawidson IJ.

Pancreas. 1996 Nov;13(4):372-80.PMID: 8899797 [PubMed - indexed for MEDLINE]Related articles